Comments

BioCryst Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does BioCryst Pharma (BCRX) operate in?

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BCRXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$10.59

0.201.92%

At close: -

$10.51

-0.08-0.74%

After Hours: May 23, 6:50 PM EDT

BioCryst Pharma (BCRX) Forecast

News Earnings BioCryst Pharma (BCRX) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

BioCryst Pharma Stock Price, Quotes and Forecasts | NASDAQ:BCRX | Benzinga

Explore BioCryst Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BCRX.

Open	$10.29
Close	$10.59
Volume / Avg.	3.61M / 4.70M
Day Range	$10.16 - $10.59
52 Wk Range	5.92 - 11.11
Market Cap	$2.20B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	65
Short Interest	8.78%
Days to Cover	4.78

Recent News

BioCryst Pharmaceuticals Soars 23% In One Session - Here's Why It Surprised Investors

BioCryst posted $134.2 million in Q1 revenue, raised 2025 Orladeyo guidance, and now expects full-year profitability and positive cash flow.

Vandana Singh

Crude Oil Falls Over 2%; ISM Services PMI Rises In April

Avi Kapoor

Napco Security Technologies Posts Better-Than-Expected Results, Joins Skechers, BioCryst Pharmaceuticals And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$10.29
Close	$10.59
Volume / Avg.	3.61M / 4.70M
Day Range	$10.16 - $10.59
52 Wk Range	5.92 - 11.11
Market Cap	$2.20B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	65
Short Interest	8.78%
Days to Cover	4.78

About Biocryst Pharmaceuticals Inc.

Sector

Health Care

Industry

Biotechnology

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and developm...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BioCryst Pharma (BCRX) stock?

You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.

View our list of the best stock brokerages

Who are BioCryst Pharma (BCRX) competitors?

Other companies in BioCryst Pharma’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Ascentage Pharma Group (NASDAQ:AAPG) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for BioCryst Pharma (BCRX) stock?

BioCryst Pharma has a consensus price target of $15.73.

What is the current price for BioCryst Pharma (BCRX)?

The stock price for BioCryst Pharma (NASDAQ: BCRX) is $10.5117 last updated May 23, 2025 at 6:50 PM EDT.

Does BioCryst Pharma (BCRX) pay a dividend?

There are no upcoming dividends for BioCryst Pharma.

When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?

BioCryst Pharma’s Q2 earnings are confirmed for Monday, August 4, 2025.

Is BioCryst Pharma (BCRX) going to split?

There is no upcoming split for BioCryst Pharma.

What sector and industry does BioCryst Pharma (BCRX) operate in?

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.